Plain-English translation of NCT06972368 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called transcranial direct current stimulation (tDCS) — a non-invasive device that sends mild electrical currents to specific parts of your brain to help reduce depression. You would use the device at home twice a day for about a week. Half of participants will receive active treatment, and half will receive a placebo (sham) treatment that feels the same but doesn't deliver the electrical current.
Depression is very common in people with borderline personality disorder and is often hard to treat with standard medications or therapy alone. This new treatment aims to address depression in a different way by stimulating the brain directly, potentially offering relief when other treatments haven't worked well enough.
You likely qualify if…
You likely don't qualify if…
You'll start with two weeks of online learning about your condition. Then you'll receive a tDCS device to use at home and perform 14 sessions over one week — twice daily for 30 minutes each, with at least 2 hours between sessions. You'll have check-ins at the start, right after treatment ends, and again up to three months later. The study team will track your depression symptoms and overall well-being throughout.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
Canada